-
ILCSC Session Highlight: Histological Transformation of NSCLC into SCLC
Do you want to learn more about NSCLC transformation to SCLC? Join us for the International Lung Cancer Survivorship Conference and tune into Dr. Triparna Sen's (Icahn School of Medicine at Mount...
IN THE SPOTLIGHT
-
ILCSC Session Highlight: Addressing Brain Mets in Lung Cancer
Leading lung cancer expert Dr. Manmeet Ahluwalia (Miami Cancer Institute) discusses brain metastases in people living with lung cancer. Register for free for the virtual... -
What's new in RET-positive lung cancer: Moving beyond tyrosine kinase inhibitors
This recorded Facebook Live presentation features guest speakers Nicolas Le-Bel (caregiver and member of the RETpositive patient group) and Dr. Alex Drilon (Thoracic Oncologist &... -
Decentralized Trials: Bringing Clinical Trials Closer to the Patient
While participating in clinical trials can provide substantial benefits to people with lung cancer, the resources required to do so may pose significant hurdles, especially to... -
Moving beyond tyrosine kinase inhibitors: What's new in RET-positive lung cancer
Come join us for an interactive Facebook Live with guest speakers Nicolas Le-Bel (caregiver and member of the RETpositive patient group) and Dr. Alex Drilon (Thoracic Oncologist &... -
LUNGevity's International Lung Cancer Survivorship Conference
LUNGevity's 2023 International Lung Cancer Survivorship Conference features something for everyone! Our lineup of internationally renowned lung cancer experts will be covering a... -
Rare Mutations (RET, ROS1, MET, BRAF) Virtual Meetup
Rare Mutation (RET, ROS1, MET, BRAF) patients/survivors - Join us the 1st Wednesday of every month to connect with others who share common experiences and build your community... -
2023 ASCO: Highlights of Lung Cancer Research
Recently, members of LUNGevity Foundation joined thousands of attendees from the US and around the world, including oncologists, scientists, biotech and pharmaceutical... -
Navigating Hope: How Comprehensive Biomarker Testing is Guiding Lung Cancer Care
Join us for a discussion on lung cancer biomarkers to learn what biomarker testing is, why it’s important, and how it can be used to optimize your treatment plans. We are thrilled... -
Tracing the Clues of a Global Killer: How Dr. Charles Swanton’s Research Is Shedding New Light on Lung Cancer
As Chief Investigator of the groundbreaking Cancer Research UK (CRUK) TRACERx study, you could say that Dr. Charles Swanton is having a moment. Launched nine years ago, TRACERx...